By confirming the prognostic relevance of GPR across a diverse ICU population, our findings suggest this biomarker could play a critical role in advancing sepsis management protocols, potentially guiding therapeutic decisions to mitigate mortality risks more effectively. Here, ALDH18A1 is linked to Sepsis.